Biological function analysis identified downregulated genes in angiogenesis and vasculogenesis as downstream components of IL-6, IL-8, and HGF pathways suggesting a regulatory network of reduced angiogenic potential in GDM-CMSCs. The gene discussed is IL6; the disease is gestational diabetes.